Contenu disponible en anglais seulement.

Examen de radiation de la TSX - Aptose Biosciences Inc. (APS)

16 janvier 2026
Issuer: Aptose Biosciences Inc. (the "Company")
Securities:

Common Shares

Symbol(s): APS
Delisting Review Type: Remedial
Delisting Review Period: TSX has decided to further extend its review of the eligibility of the Common Shares of the Company for continued listing for a period of 60 days.
Additional Information: Please refer to TSX Bulletin 2025-0836 dated September 24, 2025.
TSX Contact: Selma Thaver,
Managing Director,
TSX Listings